Previous 10 | Next 10 |
The pet healthcare industry has been among the major beneficiaries of the pandemic as working-from-home arrangements have afforded workers more time to care for their pets. IDEXX Laboratories’ (IDXX) improving financials owing to this trend should allow the stock keep soaring in the up...
The number of households that own a pet is expected to increase from 68 million to 71 million by the end of this year. About 94% of the pet-owning households in the U.S. own either a dog or cat. That's good news for companies that serve the market for pet supplies like food, medicine, and i...
On November 15th, institutional investment managers with more than $100 million AUM had to disclosed their positions at the end of Q3 2020. Several stocks stand out when we look at the form 13F of some of the best-performing hedge funds. Focusing on the very best ideas, I reviewed...
IDEXX Laboratories Elects Dr. Asha S. Collins to Board of Directors PR Newswire WESTBROOK, Maine, Nov. 12, 2020 WESTBROOK, Maine , Nov. 12, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary...
Image source: The Motley Fool. IDEXX Laboratories Inc (NASDAQ: IDXX) Q3 2020 Earnings Call Oct 30, 2020 , 8:30 p.m. ET Operator Continue reading For further details see: IDEXX Laboratories Inc (IDXX) Q3 2020 Earnings Call Transcript
IDEXX Laboratories, Inc. (IDXX) Q3 2020 Earnings Conference Call October 29, 2020, 08:30 AM ET Company Participants Jay Mazelsky - President and CEO Brian McKeon - CFO John Ravis - Senior Director, IR Conference Call Participants Ryan Daniels - William Blair Erin Wright - Credit Suisse Michae...
IDEXX Laboratories (IDXX) Q3 results:Revenue: $721.79M (+19.2% Y/Y) vs consensus of $672.48M, Companion Animal Group: $638M (+19.7%).Net income: $146.2M (+34.4%); GAAP EPS: $1.69 (+36.3%).Cash flow ops (9 mo.): $429.1M (+41.3%).No guidance provided, due to the unpredictability of po...
IDEXX Laboratories (IDXX): Q3 Non-GAAP EPS of $1.75 beats by $0.31; GAAP EPS of $1.69 beats by $0.27.Revenue of $721.79M (+19.2% Y/Y) beats by $49.31M.Shares +2.63% PM.Press Release For further details see: IDEXX Laboratories EPS beats by $0.31, beats on revenue
IDEXX Laboratories (NASDAQ:IDXX) is scheduled to announce Q3 earnings results on Thursday, October 29th, before market open.The consensus EPS Estimate is $1.44 (+16.1% Y/Y) and the consensus Revenue Estimate is $672.48M (+11.1% Y/Y).Gross and operating margin is estimated at 57.5% and 24.0% r...
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. A list of cheap stocks. For further details see: Healthcare: XLV Survey For October
News, Short Squeeze, Breakout and More Instantly...
IDEXX Laboratories Inc. Company Name:
IDXX Stock Symbol:
NASDAQ Market:
IDEXX Laboratories Inc. Website:
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will now host its 2024 second quarter conference call and webcast at 9:00 am ET on Tuesday, August 6, 2024, to minimize conflicts with other industry earnings announcements. Individuals can access a live ...
IDEXX Releases 2023 Corporate Responsibility Report, Highlighting Progress Against Its Goals PR Newswire WESTBROOK, Maine , July 30, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today published i...
2024-07-19 00:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...